Has Curran Uppaluri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,064 in general payments to Curran Uppaluri, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Curran Uppaluri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Curran Uppaluri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Curran Uppaluri, MD

Urology · Chapel Hill, NCNPI 1710548789

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 35.7% of the total. Reporting peaked in 2023 at $1,095 and has fallen 70.3% since, to $326 in 2025. That places this record below the midpoint for urology clinicians in NC, where the typical reported total is $2,562.

$3,064in general payments, 2019–2025

Across 60 payments — averaging $51.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Medtronic$397
Urogen Pharma, Inc.$236
Janssen Scientific Affairs, LLC$235
AbbVie$162
Bard Peripheral Vascular, Inc.$150
plus $792 from 11 others

What the payments were for

Food & beverage$3,064100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	18	$1,093
Medtronic	7	$397
Urogen Pharma, Inc.	2	$236
Janssen Scientific Affairs, LLC	2	$235
AbbVie	7	$162
Bard Peripheral Vascular, Inc.	2	$150
Teleflex LLC	2	$138
Procept Biorobotics Corporation	3	$136
AstraZeneca	2	$118
Johnson & Johnson	4	$108
Sumitomo Pharma America, Inc.	3	$67
Coloplast	2	$61
Tolmar, Inc.	2	$49
Astellas Pharma US Inc	1	$43
Bayer	1	$32
Merck	1	$22
Astellas Pharma Global Development	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LithoVue$344
INTERSTIM$229
GENERAL ERECTILE DYSFUNCTION$129
Bard BrachySource I-125 Implant Seeds In ReadyLink$127
JELMYTO$125
Balversa$122
UroLift$113
Erleada$112

How this compares

$3,064 in reported general payments places this provider in the 50th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$2,108

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	20	$113

Paid to pharmacies, not to this prescriber.

Other urology in Chapel Hill

Culley CarsonChapel Hill$275K
Mathew RaynorChapel Hill$61K
Davis ViprakasitChapel Hill$37K
Gopal NarangChapel Hill$31K
David FriedlanderChapel Hill$26K
David JohnsonChapel Hill$25K
Marc RogersChapel Hill$12K
Robert LippittSmithfield$11.4M
Michael KennellyCharlotte$1.3M
John KasparRaleigh$1.1M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →